The Web Survey Core (Webcore) was established in 2008. The mission of the Core is to create software applications and provide hardware requirements to allow entry of survey data via the web, particularly with respect to patient-reported outcomes. The work of the Webcore enhances the scientific objectives of the Center's research programs in three ways: 1) MSKCC investigators can use Webcore to improve the efficiency and accuracy of patient-reported outcomes for clinical studies;2) Webcore provides a ready-made interface for research staff data entry for multicenter studies;3) use of Webcore for efficient collection of patient-reported outcomes is now part of routine care in several services, facilitating retrospective, observational research. To date, the Webcore has created over 200 surveys implemented at 84 different sites nationwide. Over 25,000 Individuals have taken a Webcore survey, with a total of 40,000 total surveys taken. The services provided by the Web Survey Core have supported the research of 16 investigators in the past year. During the past grant period the work of the Core has contributed to 41 publications of researchers from 2 research programs. For example, the Webcore was instrumental in a recent R21- supported examination of psychological intervention to improve rehabilitation and decrease stress associated with erectile dysfunction. The Webcore's services were used for patients to report data on psychological and sexual endpoints.
The Webcore creates software applications and provides hardware solutions for the procurement and assessment of patient survey data. Thus this Core provides an essential resource for accurate and efficient data gathering on patient-reported outcomes fundamental to the Center's mission of quality of life care.
|Steuer, Conor E; Behera, Madhusmita; Berry, Lynne et al. (2016) Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium. Cancer 122:766-72|
|Dominguez-Rosado, Ismael; Moutinho Jr, Vitor; DeMatteo, Ronald P et al. (2016) Outcomes of the Memorial Sloan Kettering Cancer Center International General Surgical Oncology Fellowship. J Am Coll Surg 222:961-6|
|Iasonos, Alexia; O'Quigley, John (2016) Integrating the escalation and dose expansion studies into a unified Phase I clinical trial. Contemp Clin Trials 50:124-34|
|Ulaner, Gary A; Hyman, David M; Ross, Dara S et al. (2016) Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT. J Nucl Med 57:1523-1528|
|Brown, Anna M; Nagala, Sidhartha; McLean, Mary A et al. (2016) Multi-institutional validation of a novel textural analysis tool for preoperative stratification of suspected thyroid tumors on diffusion-weighted MRI. Magn Reson Med 75:1708-16|
|Akkari, Leila; Gocheva, Vasilena; Quick, Marsha L et al. (2016) Combined deletion of cathepsin protease family members reveals compensatory mechanisms in cancer. Genes Dev 30:220-32|
|Theilen, Till M; Chou, Alexander J; Klimstra, David S et al. (2016) Esophageal Adenocarcinoma and Squamous Cell Carcinoma in Children and Adolescents: Report of 3 Cases and Comprehensive Literature Review. J Pediatr Surg Case Rep 5:23-29|
|Robinson, June K; Halpern, Allan C (2016) Cost-effective Melanoma Screening. JAMA Dermatol 152:19-21|
|Calzavara-Pinton, Pier Giacomo; Rossi, Maria Teresa; Zanca, Arianna et al. (2016) Oral Polypodium leucomotos increases the anti-inflammatory and melanogenic responses of the skin to different modalities of sun exposures: a pilot study. Photodermatol Photoimmunol Photomed 32:22-7|
|Ripley, R Taylor; Suzuki, Kei; Tan, Kay See et al. (2016) Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non-small cell lung cancer. J Thorac Cardiovasc Surg 151:969-77, 979.e1-3|
Showing the most recent 10 out of 4768 publications